Results 121 to 130 of about 99,431 (234)

Vaccination and transfusion safety at the time of expanding use of live attenuated vaccines

open access: yes
Vox Sanguinis, EarlyView.
Pierre Tiberghien   +4 more
wiley   +1 more source

Burden of Influenza and Cost‐Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in India

open access: yesInfluenza and Other Respiratory Viruses, Volume 20, Issue 5, May 2026.
ABSTRACT Background In India, no publicly funded seasonal influenza immunization is ongoing, partly because cost‐effectiveness is yet to be established. We estimate the cost‐effectiveness and budgetary impact of introducing seasonal influenza vaccination among adults aged ≥ 60 years in India, a known high‐risk group. Methods Estimates of disease burden
Anand Krishnan   +19 more
wiley   +1 more source

Vaccination Coverage and Factors Associated With Incomplete Vaccination Schedules in Children Under 5 in a Peripheral Area of the Federal District of Brazil

open access: yesPublic Health Nursing, Volume 43, Issue 3, Page 543-553, May/June 2026.
ABSTRACT Objective To estimate vaccination coverage (VC) and analyze the factors associated with the incomplete vaccination schedule (IVS) in children under 5 years of age in two Basic Health Units in the Federal District of Brazil. Design A cross‐sectional study.
Ivea Rayane Mendes Nicacio Viana   +1 more
wiley   +1 more source

Measles Control in Nigeria: the Case for a Two-dose Vaccine Policy

open access: yesNigerian Journal of Paediatrics
Summary : Despite all the efforts expended on routine immunization since the era of Expanded Programme of Immunization (EPI) later called the National Programme of Immunization (NPI), measles remains a disturbing cause of morbidity and mortality in ...
Nnebe-Agumadu U
doaj  

Global Health Implications of US Exit From WHO and Suspension of Aid

open access: yes
Public Health Challenges, Volume 5, Issue 2, June 2026.
Kenneth Chukwuebuka Egwu   +5 more
wiley   +1 more source

Measles and Measles Vaccine in Japan

open access: yesPediatrics International, 1988
Before the introduction of measles vaccine in 1971, measles was a common and well-recognized disease in Japanese children. Seroepidemiological studies conducted before the general use of the vaccine disclosed that measles epidemics differed from community to community; in rural areas, epidemics appeared at intervals of several years with the ...
openaire   +3 more sources

Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity

open access: yesmBio
Serum titers of SARS-CoV-2-neutralizing antibodies (nAbs) correlate well with protection from symptomatic COVID-19 but decay rapidly in the months following vaccination or infection.
Miguel Á. Muñoz-Alía   +13 more
doaj   +1 more source

Measles vaccine uptake and COVID-19. [PDF]

open access: yesHum Vaccin Immunother, 2023
Daungsupawong H, Wiwanitkit V.
europepmc   +1 more source

Review of Varicella zoster virus : from epidemiology to prevention [PDF]

open access: yes, 2008
The Varicella zoster virus is a human pathogen which causes Varicella after primary infection and herpes zoster after secondary reactivation. Both disease manifestations can occur at any age; however, Varicella is seen more commonly in children whilst ...
Pace, David
core  

Home - About - Disclaimer - Privacy